Texas company launches sweeping lawsuits against five major players, alleging infringement of medical device patents tied to ...

Pharma giant dodges threat as US judge dismisses monopoly claims over its blockbuster cancer drug | FDA approves new ...

AstraZeneca fends off diabetes generic, for now ...

The Düsseldorf court’s decision offers an instructive perspective on the legal nature of patent pledges as well as a reminder ...

EPO: Biotech innovation strong, while pharma trails behind ...

The court hands Edwards Lifesciences a win in its long-running battle with Meril | Panel issues a second Europe-wide ...

Ahead of the upcoming LSPN North America-Spring 2025 conference, chair Eldora Ellison shares insights on emerging innovations ...